Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

| BSE 1158.70 -8.50 (-0.73%) | |

BSE Live

Jan 20, 10:39
1158.70 -8.50 (-0.73%)
Volume
AVERAGE VOLUME
5-Day
11,467
10-Day
24,776
30-Day
23,362
3,623

  • Prev. Close

    1167.20

  • Open Price

    1167.20

  • Bid Price (Qty.)

    1160.05 (2)

  • Offer Price (Qty.)

    1161.35 (49)

NSE Live

Jan 20, 10:39
1160.60 -7.00 (-0.60%)
Volume
AVERAGE VOLUME
5-Day
745,202
10-Day
1,034,613
30-Day
802,479
157,203

  • Prev. Close

    1167.60

  • Open Price

    1167.60

  • Bid Price (Qty.)

    1160.20 (11)

  • Offer Price (Qty.)

    1160.70 (48)

Financials

Cash Flow of Aurobindo Pharma (in Rs. Cr.) Mar 10 Mar 09 Mar 08 Mar 07 Mar 06  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 710.15 157.04 344.84 231.16 92.90  
Net CashFlow From Operating Activities 344.66 4.88 105.47 49.48 3.78  
Net Cash Used In Investing Activities -406.21 -301.73 -12.00 -606.64 -232.01  
Net Cash Used From Financing Activities -14.15 160.97 -185.45 723.43 356.58  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -75.70 -135.88 -91.98 166.27 128.35  
Cash And Cash Equivalents Begin of Year 79.79 209.22 298.99 144.13 13.80  
Cash And Cash Equivalents End Of Year 4.09 73.34 207.01 310.40 142.15  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347